Skip to main content
. 2020 Nov 17;21(22):8679. doi: 10.3390/ijms21228679

Figure 4.

Figure 4

Outputs from upstream kinase identification pipelines for the patient-derived PDCL5 PDAC cell line compared to patient-derived wild-type pancreatic tissue. (A) Kinome Random Sampling Analyzer (KRSA); (B) Post-Translational Modification Signature Enrichment Analysis (PTM-SEA); (C) Kinase Enrichment Analysis Version 3 (KEA3); (D) Upstream Kinase Analysis (UKA). (E) Quartile summary. A more detailed figure legend can be found in Appendix B.